{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:50:13Z","timestamp":1790232613480,"version":"4.1.0"},"reference-count":99,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Myocardial relaxation and stiffness are influenced by fibrillar collagen content. Cyclic nucleotide signaling regulators have been investigated targeting more effective modulation of collagen deposition during myocardial healing process. To assess the effects of phosphodiesterase type 3 and phosphodiesterase type 5 inhibitors on cardiac function and left ventricular myocardial fibrosis in catecholamine-induced myocardial injury, sildenafil and pimobendan were administered to male Wistar rats 24 hours after isoproterenol injection. Echocardiography and electrocardiogram were performed to assess kinetic and rhythm changes during 45 days of drug administration. At the end of study, type I and type III collagen were measured through immunohistochemistry analysis, and left ventricular pressure was assessed through invasive method. Echocardiography assessment showed increased relative wall thickness at 45 days in pimobendan group with significant diastolic dysfunction and increased collagen I deposition compared with nontreated positive group (3.03 \u00b1 0.31 vs. 2.73 \u00b1 0.28%, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05). Diastolic pressure correlated positively with type I collagen (r = 0.54, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05). Type III collagen analysis did not demonstrate difference among the groups. Sildenafil administration attenuated type I collagen deposition (2.15 \u00b1 0.51 vs. positive group, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05) and suggested to be related to arrhythmic events. Arrhythmic events were not related to the quantity of fibrillar collagen deposition. Although negative modulation of collagen synthesis through cyclic nucleotides signaling have shown promising results, in this study, pimobendan postconditioning resulted in increased collagen type I formation and severe diastolic dysfunction while sildenafil postconditioning reduced collagen type I deposition and attenuated diastolic dysfunction.<\/jats:p>","DOI":"10.1097\/fjc.0000000000000652","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T21:58:41Z","timestamp":1551823121000},"page":"195-205","source":"Crossref","is-referenced-by-count":14,"title":["Contrasting Effects of Inhibition of Phosphodiesterase 3 and 5 on Cardiac Function and Interstitial Fibrosis in Rats With Isoproterenol-Induced Cardiac Dysfunction"],"prefix":"10.1097","volume":"73","author":[{"given":"Telma Mary","family":"Nakata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryou","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230911","doi-asserted-by":"crossref","first-page":"35823","DOI":"10.1038\/srep35823","article-title":"Optical metrics of the extracellular matrix predict compositional and mechanical changes after myocardial infarction","volume":"6","author":"Quinn","year":"2016","journal-title":"Sci Rep."},{"key":"R2-20230911","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/0735-1097(89)90360-4","article-title":"Cardiac interstitium in health and disease: the fibrillar collagen network","volume":"13","author":"Weber","year":"1989","journal-title":"J Am Coll Cardiol."},{"key":"R3-20230911","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2012.10.002","article-title":"Heart failure","volume":"1","author":"Braunwald","year":"2013","journal-title":"JACC Heart Fail."},{"key":"R5-20230911","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1755-1536-6-5","article-title":"Function and fate of myofibroblasts after myocardial infarction","volume":"6","author":"Turner","year":"2013","journal-title":"Fibrogenesis Tissue Repair."},{"key":"R6-20230911","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1073\/pnas.0408704102","article-title":"Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylyl cyclase","volume":"102","author":"Swaney","year":"2005","journal-title":"Proc Natl Acad Sci U S A."},{"key":"R7-20230911","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.pharmthera.2009.02.009","article-title":"Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics","volume":"122","author":"Tsai","year":"2009","journal-title":"Pharmacol Ther."},{"key":"R8-20230911","doi-asserted-by":"crossref","first-page":"12944","DOI":"10.1074\/jbc.M404706200","article-title":"Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling","volume":"280","author":"Das","year":"2005","journal-title":"J Biol Chem."},{"key":"R9-20230911","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nm1175","article-title":"Chronic inhibition of cyclic GMP phosphodiesterase 5A","volume":"11","author":"Takimoto","year":"2005","journal-title":"Nat Med."},{"key":"R10-20230911","first-page":"144","article-title":"Histological and immunohistochemical study of cardio protective effect of sildenafil against isoproterenol induced cardiotoxicity in male rats","volume":"42","author":"Mahmood","year":"2017","journal-title":"Int J Pharm Sci Rev Res."},{"key":"R11-20230911","doi-asserted-by":"crossref","first-page":"12925","DOI":"10.1073\/pnas.1414364111","article-title":"Roles of cGMP-dependent protein kinase I (cGKI) and PDE5 in the regulation of Ang II-induced cardiac hypertrophy and fibrosis","volume":"111","author":"Patrucco","year":"2014","journal-title":"Proc Natl Acad Sci U S A."},{"key":"R12-20230911","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1124\/jpet.115.226092","article-title":"Sildenafil does not prevent heart hypertrophy and fibrosis induced by cardiomyocyte angiotensin II type 1 receptor signaling","volume":"354","author":"Straubinger","year":"2015","journal-title":"J Pharmacol Exp Ther."},{"key":"R13-20230911","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1124\/mol.113.087742","article-title":"Increase in cellular cyclic AMP concentrations reverses the profibrogenic phenotype of cardiac myofibroblasts: a novel therapeutic approach for cardiac fibrosis","volume":"84","author":"Lu","year":"2013","journal-title":"Mol Pharmacol."},{"key":"R14-20230911","first-page":"41","article-title":"Hemodynamic effects of intravenous pimobendan in patients with left ventricular dysfunction","volume":"14","author":"Remme","year":"1989","journal-title":"J Cardiovasc Pharmacol."},{"key":"R15-20230911","first-page":"103","article-title":"Mechanoenergetic effect of pimobendan in failing dogs hearts","volume":"S12","author":"Goto","year":"1997","journal-title":"Heart Vessels."},{"key":"R16-20230911","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1161\/01.CIR.85.3.942","article-title":"Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Results of a multicenter trial","volume":"85","author":"Kubo","year":"1992","journal-title":"Circulation."},{"key":"R17-20230911","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1253\/circj.66.149","article-title":"Effects of pimobendan on adverse cardiac events and physical activities in patients with mild to moderate chronic heart failure: the effects of pimobendan on chronic heart failure study (EPOCH study)","volume":"66","year":"2002","journal-title":"Circ J."},{"key":"R18-20230911","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1111\/bph.13062","article-title":"Stage-dependent benefits and risks of pimobendan in mice with genetic dilated cardiomyopathy and progressive heart failure","volume":"172","author":"Nonaka","year":"2015","journal-title":"Br J Pharmacol."},{"key":"R19-20230911","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00395-003-0401-3","article-title":"Transthoracic echocardiography in rats. Evaluation of commonly used indices of left ventricular dimensions, contractile performance, and hypertrophy in a genetic model of hypertrophic heart failure (SHHF-Mcc-facp-rats) in comparison with Wistar rats during aging","volume":"98","author":"Reffelmann","year":"2003","journal-title":"Basic Res Cardiol."},{"key":"R20-20230911","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1161\/CIRCULATIONAHA.111.065300","article-title":"Long-term effects of sildenafil in a rat model of chronic mitral regurgitation: benefits of ventricular remodeling and exercise capacity","volume":"125","author":"Kim","year":"2012","journal-title":"Circulation."},{"key":"R21-20230911","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1124\/jpet.115.227850","article-title":"Concomitant phosphodiesterase 5 inhibition enhances myocardial protection by inhaled nitric oxide in ischemia-reperfusion injury","volume":"356","author":"Lux","year":"2016","journal-title":"J Pharmacol Exp Ther."},{"key":"R22-20230911","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr."},{"key":"R23-20230911","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/hrt.2008.142083","article-title":"Alterations in myocardial stiffness in elite athletes assessed by a new Doppler index","volume":"94","author":"King","year":"2008","journal-title":"Heart."},{"key":"R24-20230911","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods."},{"key":"R25-20230911","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/0192623309357948","article-title":"Cardiac troponin I in isoproterenol-induced cardiac injury in the Hanover Wistar rat: studies on low dose levels and routes of administration","volume":"38","author":"Brady","year":"2010","journal-title":"Toxicol Pathol."},{"key":"R26-20230911","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/cvr\/27.2.192","article-title":"Increased responsiveness of left ventricular apical myocardium to adrenergic stimuli","volume":"27","author":"Mori","year":"1993","journal-title":"Cardiovasc Res."},{"key":"R27-20230911","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1258\/002367706776319042","article-title":"Cardiac troponin I is a sensitive, specific biomarker of cardiac injury in laboratory animals","volume":"40","author":"O'Brien","year":"2006","journal-title":"Lab Anim."},{"key":"R28-20230911","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1080\/01926230701389316","article-title":"Characterization of troponin responses in isoproterenol-induced cardiac injury in the Hanover Wistar rat","volume":"35","author":"York","year":"2007","journal-title":"Toxicol Pathol."},{"key":"R29-20230911","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.taap.2013.11.011","article-title":"Isoproterenol effects evaluated in heart slices of human and rat in comparison to rat heart in vivo","volume":"274","author":"Herrmann","year":"2014","journal-title":"Toxicol Appl Pharmacol."},{"key":"R30-20230911","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0022-2828(85)80064-X","article-title":"Experimental catecholamine-induced myocardial necrosis. II. Temporal development of isoproterenol-induced contraction band lesions correlated with ECG, hemodynamic and biochemical changes","volume":"17","author":"Todd","year":"1985","journal-title":"J Mol Cell Cardiol."},{"key":"R31-20230911","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/phrs.1998.0365","article-title":"Lipid peroxidation and antioxidant enzymes in isoproterenol induced oxidative stress in rat tissues","volume":"38","author":"Rathore","year":"1998","journal-title":"Pharmacol Res."},{"key":"R32-20230911","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/01.RES.65.3.657","article-title":"Isoproterenol-induced myocardial fibrosis in relation to myocardial necrosis","volume":"65","author":"Benjamin","year":"1989","journal-title":"Circ Res."},{"key":"R33-20230911","first-page":"H1086","article-title":"Severe myocardial dysfunction induced by ventricular remodeling in aging rat hearts","volume":"259","author":"Capasso","year":"1990","journal-title":"Am J Physiol."},{"key":"R34-20230911","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ejcts.2006.07.006","article-title":"The relationship between myocardial extracellular matrix remodeling and ventricular function","volume":"30","author":"Brower","year":"2006","journal-title":"Eur J Cardiothorac Surg."},{"key":"R35-20230911","first-page":"325","article-title":"Collagen remodeling after myocardial infarction in the rat heart","volume":"147","author":"Cleutjens","year":"1995","journal-title":"Am J Pathol."},{"key":"R36-20230911","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0008-6363(00)00003-1","article-title":"Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling","volume":"46","author":"Li","year":"2000","journal-title":"Cardiovasc Res."},{"key":"R37-20230911","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0140-6736(06)68074-4","article-title":"Controversies in ventricular remodelling","volume":"367","author":"Opie","year":"2006","journal-title":"Lancet."},{"key":"R38-20230911","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/FJC.0b013e318207a35f","article-title":"Fibrosis and cardiac arrhythmias","volume":"57","author":"de Jong","year":"2011","journal-title":"J Cardiovasc Pharmacol."},{"key":"R39-20230911","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/cvr\/cvs142","article-title":"A pro-fibrotic role for interleukin-4 in cardiac pressure overload","volume":"95","author":"Kanellakis","year":"2012","journal-title":"Cardiovasc Res."},{"key":"R40-20230911","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/CIRCRESAHA.110.224428","article-title":"Lack of fibronectin-EDA promotes survival and prevents adverse remodeling and heart function deterioration after myocardial infarction","volume":"108","author":"Arslan","year":"2011","journal-title":"Circ Res."},{"key":"R41-20230911","doi-asserted-by":"crossref","first-page":"H1456","DOI":"10.1152\/ajpheart.00316.2011","article-title":"Effects of mechanical limitation of apical rotation on left ventricular relaxation and end-diastolic pressure","volume":"301","author":"Iwasaki","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"R42-20230911","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1124\/jpet.105.090324","article-title":"Fibrotic lung fibroblasts show blunted inhibition by camp due to deficient cAMP response element-binding protein phosphorylation","volume":"315","author":"Liu","year":"2005","journal-title":"J Pharmacol Exp Ther."},{"key":"R43-20230911","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1096\/fj.00-0538com","article-title":"Cardiac phosphodiesterase 5 (cGMP-specific) modulates beta-adrenergic signaling in vivo and is down-regulation in heart failure","volume":"15","author":"Senzaki","year":"2001","journal-title":"FASEB J."},{"key":"R44-20230911","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ijcard.2015.10.240","article-title":"Calcium sensitizers: what have we learned over the last 25 years?","volume":"203","author":"Pollesello","year":"2016","journal-title":"Int J Cardiol."},{"key":"R45-20230911","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1536\/ihj.54.75","article-title":"Efficacy and limitations of oral inotropic agents for the treatment of chronic heart failure","volume":"54","author":"Murai","year":"2013","journal-title":"Int Heart J."},{"key":"R46-20230911","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0735-1097(01)01548-0","article-title":"Long-term administration of amlodipine prevents decompensation to diastolic heart failure in hypertensive rats","volume":"38","author":"Nishikawa","year":"2001","journal-title":"J Am Coll Cardiol."},{"key":"R47-20230911","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/0022-2828(90)90079-H","article-title":"Enhanced deposition of predominantly type I collagen in myocardial disease","volume":"22","author":"Bishop","year":"1990","journal-title":"J Mol Cell Cardiol."},{"key":"R48-20230911","doi-asserted-by":"crossref","first-page":"H889","DOI":"10.1152\/ajpheart.00967.2001","article-title":"Acute and specific collagen type I degradation increases diastolic and developed tension in perfused rat papillary muscle","volume":"286","author":"Lamberts","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"R49-20230911","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1161\/01.RES.67.6.1474","article-title":"Collagen phenotypes during development and regression of myocardial hypertrophy in spontaneously hypertensive rats","volume":"67","author":"Mukherjee","year":"1990","journal-title":"Circ Res."},{"key":"R50-20230911","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jacc.2010.10.024","article-title":"Diastolic tissue Doppler indexes correlate with the degree of collagen expression and cross-linking in heart failure and normal ejection fraction","volume":"57","author":"Kasner","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"R51-20230911","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/01.CIR.0000135591.37759.AF","article-title":"Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy","volume":"110","author":"Nagueh","year":"2004","journal-title":"Circulation."},{"key":"R52-20230911","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/BF00171739","article-title":"Antagonism of novel inotropic agents at A1 adenosine receptors and m-cholinoceptors in human myocardium","volume":"341","author":"Ungerer","year":"1990","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"R53-20230911","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00005344-200102000-00008","article-title":"Increase in myofibrillar Ca2+ sensitivity induced by UD-CG 212 Cl, an active metabolite of pimobendan, in canine ventricular myocardium","volume":"37","author":"Takahashi","year":"2001","journal-title":"J Cardiovasc Pharmacol."},{"key":"R54-20230911","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(99)00559-2","article-title":"Effects of adrenomedullin on cultured rat cardiac myocytes and fibroblasts","volume":"382","author":"Horio","year":"1999","journal-title":"Eur J Pharmacol."},{"key":"R55-20230911","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1165\/rcmb.2002-0243OC","article-title":"Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation","volume":"29","author":"Kolodsick","year":"2003","journal-title":"Am J Respir Cell Mol Biol."},{"key":"R56-20230911","doi-asserted-by":"crossref","first-page":"H3216","DOI":"10.1152\/ajpheart.00739.2007","article-title":"Adenylyl cyclase activity and function are decreased in rat cardiac fibroblasts after myocardial infarction","volume":"293","author":"Swaney","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"R57-20230911","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1527-3466.1988.tb00380.x","article-title":"Pimobendan","volume":"6","author":"Kitzen","year":"1989","journal-title":"Cardiovasc Drug Rev."},{"key":"R58-20230911","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1161\/hc3201.092216","article-title":"Cardioprotective effect afforded by transient exposure to phosphodiesterase III inhibitors: the role of protein kinase A and p38 mitogen-activated protein kinase","volume":"104","author":"Sanada","year":"2001","journal-title":"Circulation."},{"key":"R59-20230911","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1161\/01.CIR.0000165128.39715.87","article-title":"Functional role of phosphodiesterase 3 in cardiomyocyte apoptosis: implication in heart failure","volume":"111","author":"Ding","year":"2005","journal-title":"Circulation."},{"key":"R60-20230911","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.yjmcc.2013.08.003","article-title":"Cyclic nucleotide phosphodiesterase 3A1 protects the heart against ischemia-reperfusion injury","volume":"64","author":"Oikawa","year":"2013","journal-title":"J Mol Cell Cardiol."},{"key":"R61-20230911","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pharmthera.2016.03.014","article-title":"Novel approaches to targeting PDE3 in cardiovascular disease","volume":"163","author":"Movsesian","year":"2016","journal-title":"Pharmacol Ther."},{"key":"R62-20230911","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.jacc.2016.12.037","article-title":"A test in context: E\/A and E\/e' to assess diastolic dysfunction and LV filling pressure","volume":"69","author":"Mitter","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"R63-20230911","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.echo.2003.10.010","article-title":"Baseline echocardiographic values for adult male rats","volume":"17","author":"Watson","year":"2004","journal-title":"J Am Soc Echocardiogr."},{"key":"R64-20230911","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.euje.2006.03.009","article-title":"Doppler myocardial imaging in adult male rats: reference values and reproducibility of velocity and deformation parameters","volume":"7","author":"Weytjens","year":"2006","journal-title":"Eur J Echocardiogr."},{"key":"R65-20230911","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/01.CIR.102.15.1788","article-title":"Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study","volume":"102","author":"Ommen","year":"2000","journal-title":"Circulation."},{"key":"R66-20230911","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jacc.2003.07.044","article-title":"Noninvasive estimation of left ventricular filling pressure by E\/e' is a powerful predictor of survival after acute myocardial infarction","volume":"43","author":"Hillis","year":"2004","journal-title":"J Am Coll Cardiol."},{"key":"R67-20230911","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of echocardiography and the European Association of Cardiovascular Imaging","volume":"29","author":"Nagueh","year":"2016","journal-title":"J Am Soc Echocardiogr."},{"key":"R68-20230911","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/4541958","article-title":"Sildenafil can affect innate and adaptive immune system in both experimental animals and patients","volume":"2017","author":"Kniotek","year":"2017","journal-title":"J Immunol Res."},{"key":"R69-20230911","doi-asserted-by":"crossref","first-page":"H342","DOI":"10.1152\/ajpheart.00306.2006","article-title":"Sildenafil-mediated acute cardioprotection is independent of the NO\/cGMP pathway","volume":"292","author":"Elrod","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"R70-20230911","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.yjmcc.2006.10.015","article-title":"Sildenafil and vardenafil but not nitroglycerin limit myocardial infarction through opening of mitochondrial K(ATP) channels when administered at reperfusion following ischemia in rabbits","volume":"42","author":"Salloum","year":"2007","journal-title":"J Mol Cell Cardiol."},{"key":"R71-20230911","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0735-1097(00)01049-4","article-title":"Sildenafil citrate (Viagra) does not exacerbate myocardial ischemia in canine models of coronary artery stenosis","volume":"37","author":"Przylenk","year":"2001","journal-title":"J Am Coll Cardiol."},{"key":"R72-20230911","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/CIRCHEARTFAILURE.110.944694","article-title":"PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study","volume":"4","author":"Guazzi","year":"2011","journal-title":"Circ Heart Fail."},{"key":"R73-20230911","doi-asserted-by":"crossref","first-page":"H2344","DOI":"10.1152\/ajpheart.00541.2006","article-title":"Left ventricular myofilament dysfunction in rat experimental hypertrophy and congestive heart failure","volume":"291","author":"Belin","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"R74-20230911","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/ejhf.135","article-title":"Rationale and design of the SOluble guanylate Cyclase stimulatoR in heArT failurE Studies (SOCRATES)","volume":"16","author":"Pieske","year":"2014","journal-title":"Eur J Heart Fail."},{"key":"R75-20230911","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/S0735-1097(98)00692-5","article-title":"Pimobendan inhibits the production of proinflammatory cytokines and gene expression of inducible nitric oxide synthase in a murine model of viral myocarditis","volume":"33","author":"Iwasaki","year":"1999","journal-title":"J Am Coll Cardiol."},{"key":"R76-20230911","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1161\/01.RES.77.3.486","article-title":"Contractile responsiveness of ventricular myocytes to isoproterenol is regulated by induction of nitric oxide synthase activity in cardiac microvascular endothelial cells in heterotypic primary culture","volume":"77","author":"Ungureanu-Longrois","year":"1995","journal-title":"Circ Res."},{"key":"R77-20230911","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/01.RES.63.5.911","article-title":"Sensitization of dog and guinea pig heart myofilaments to Ca2+ activation and the inotropic effect of pimobendan: comparison with milrinone","volume":"63","author":"Fujino","year":"1988","journal-title":"Circ Res."},{"key":"R78-20230911","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/cvr\/cvm084","article-title":"Sarcomeric proteins and inherited cardiomyopathies","volume":"77","author":"Morimoto","year":"2008","journal-title":"Cardiovasc Res."},{"key":"R79-20230911","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1073\/pnas.022628899","article-title":"Ca(2+)-desensitizing effect of a deletion mutation Delta K210 in cardiac troponin T that causes familial dilated cardiomyopathy","volume":"99","author":"Morimoto","year":"2002","journal-title":"Proc Natl Acad Sci U S A."},{"key":"R80-20230911","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.RES.77.1.107","article-title":"Effects of levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and Ca2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart","volume":"77","author":"Edes","year":"1995","journal-title":"Circ Res."},{"key":"R81-20230911","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1476-5381.1996.tb15716.x","article-title":"Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthetized dogs","volume":"119","author":"Pagel","year":"1996","journal-title":"Br J Pharmacol."},{"key":"R82-20230911","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000176673","article-title":"Relaxation within the left ventricular myocardial wall","volume":"85","author":"Aubert","year":"1994","journal-title":"Cardiology."},{"key":"R83-20230911","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF02576850","article-title":"Characterisation of left ventricular relaxation in the isolated guinea pig heart","volume":"196","author":"Sch\u00e4fer","year":"1996","journal-title":"Res Exp Med (Berl)."},{"key":"R84-20230911","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0014-2999(87)90225-1","article-title":"Cardiovascular effects of UD-CG 212 CL, a metabolite of pimobendan, in anaesthetized pigs","volume":"137","author":"Verdouw","year":"1987","journal-title":"Eur J Pharmacol."},{"key":"R85-20230911","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1113\/expphysiol.1992.sp003602","article-title":"Coronary flow and left ventricular pressure during diastole in the anaesthetized dog","volume":"77","author":"Gattullo","year":"1992","journal-title":"Exp Physiol."},{"key":"R86-20230911","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/01.CIR.102.3.275","article-title":"Sildenafil (Viagra) prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current","volume":"102","author":"Geelen","year":"2000","journal-title":"Circulation."},{"key":"R87-20230911","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1536\/ihj.20.177","article-title":"Concentration of myocardial cyclic AMP and ventricular fibrillation induced by aminophylline","volume":"20","author":"Sugiura","year":"1979","journal-title":"Jpn Heart J."},{"key":"R88-20230911","first-page":"139","article-title":"The relationship between coronary artery occlusion-induced arrhythmias and myocardial cyclic nucleotide levels in the anaesthetized rat","volume":"84","author":"Kane","year":"1985","journal-title":"Br J Pharmacol."},{"key":"R89-20230911","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0022-0736(86)80007-3","article-title":"Increased cyclic GMP in atrial fibrillation","volume":"19","author":"Uno","year":"1986","journal-title":"J Electrocardiol."},{"key":"R90-20230911","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/0735-1097(92)90629-2","article-title":"Potential arrhythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: implications for prophylactic effects of beta-blockers in myocardial infarction and proarrhythmic effects of phosphodiesterase inhibitors","volume":"19","author":"Lubbe","year":"1992","journal-title":"J Am Coll Cardiol."},{"key":"R91-20230911","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00003643-200303000-00005","article-title":"Effects of rolipram, pimobendan and zaprinast on ischaemia-induced dysrhythmias and on ventricular cyclic nucleotide content in the anaesthetized rat","volume":"20","author":"Carceles","year":"2003","journal-title":"Eur J Anaesthesiol."},{"key":"R92-20230911","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1067\/mhj.2002.121547","article-title":"Effects of sildenafil citrate (Viagra) on cardiac repolarization and on autonomic control in subjects with chronic heart failure","volume":"143","author":"Piccirillo","year":"2002","journal-title":"Am Heart J."},{"key":"R93-20230911","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF00495953","article-title":"UD-CG 115\u2014a cardiotonic pyridazinone which elevates cyclic AMP and prolongs the action potential in guinea-pig papillary muscle","volume":"325","author":"Honerj\u00e4ger","year":"1984","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"R94-20230911","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10741-009-9146-x","article-title":"Abnormalities of calcium metabolism and myocardial contractility depression in the failing heart","volume":"14","author":"Lehnart","year":"2009","journal-title":"Heart Fail Rev."},{"key":"R95-20230911","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1161\/hc3201.092285","article-title":"Heart failure after myocardial infarction: altered excitation-contraction coupling","volume":"104","author":"G\u00f3mez","year":"2001","journal-title":"Circulation."},{"key":"R96-20230911","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00005344-198811000-00008","article-title":"Effects of pimobendan (UD-CG 115 BS), a new positive inotropic agent, on ventricular tachycardia and ischemic ventricular fibrillation in a conscious canine model of recent myocardial infarction","volume":"12","author":"Lynch","year":"1988","journal-title":"J Cardiovasc Pharmacol."},{"key":"R97-20230911","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00019501-200002000-00014","article-title":"Effects of pimobendan and EGIS 9377, cardiotonic agents, and OG-VI, a nucleoside\u2013nucleotide mixture, administered during reperfusion after ischemia on stunned myocardium in dogs","volume":"11","author":"Fukutomi","year":"2000","journal-title":"Coron Artery Dis."},{"key":"R98-20230911","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/00005344-199210000-00013","article-title":"Contrasting effects of cyclic AMP increase caused by beta-adrenergic stimulation or by adenylate cyclase activation on ventricular fibrillation threshold of isolated rat heart","volume":"20","author":"Worthington","year":"1992","journal-title":"J Cardiovasc Pharmacol."},{"key":"R99-20230911","doi-asserted-by":"crossref","first-page":"H1898","DOI":"10.1152\/ajpheart.2000.279.4.H1898","article-title":"Effect of milrinone on left ventricular relaxation and Ca(2+) uptake function of cardiac sarcoplasmic reticulum","volume":"279","author":"Yano","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"R100-20230911","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cmet.2015.01.005","article-title":"Altered myocardial calcium cycling and energetics in heart failure\u2014a rational approach for disease treatment","volume":"21","author":"Gorski","year":"2015","journal-title":"Cell Metab."}],"container-title":["Journal of Cardiovascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005344-201903000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T01:19:24Z","timestamp":1694395164000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005344-201903000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":99,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/fjc.0000000000000652","relation":{},"ISSN":["0160-2446"],"issn-type":[{"value":"0160-2446","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}